Study to Evaluate the Performance of the INSTI® HCV Antibody Test for Point-of-Care Use in Individuals at Risk for HCV Infection or Presenting With Signs or Symptoms of HCV Infection

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2026
A multicenter prospective study to evaluate the clinical performance, usability, and contrived result interpretation of the INSTI® HCV Antibody Test (INSTI HCV) with fingerstick (FS) whole blood specimens from participants with signs or symptoms of hepatitis or participants at risk for hepatitis C infection, by trained operators at point of care (POC) settings. POC settings are locations where medical diagnostic testing is performed at or near the site of patient care.
Epistemonikos ID: 32d922211d1ed399ee2f1533880f68676ac076f9
First added on: Oct 30, 2026